Solventum Corp (SOLV): Total Assets
$14.29B
As of 2025-12-31
$14.24B
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.29B | -1.1% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $14.46B | +3.7% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $13.94B | n/a | 2025-02-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | $14.29B | -1.1% |
| Baxter International Inc (BAX) | 2025-12-31 | $20.05B | -22.2% |
| ResMed Inc (RMD) | 2026-06-30 | $8.97B | +9.7% |
| Dexcom Inc (DXCM) | 2025-12-31 | $6.34B | -2.2% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $43.67B | +10.9% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $55.33B | -3.4% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $4.63B | +10.2% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $4.27B | +17.2% |
| Globus Medical Inc (GMED) | 2025-12-31 | $5.30B | +1.0% |
Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗